The Newsroom of Ace Therapeutics

Ace Therapeutics Press Releases

  • Published on April 3, 2025 - 04:08 GMT

    Ace Therapeutics Unveils Advanced Animal Models to Unlock Breakthroughs in Diabetic Wound Healing

    NEW YORK, NY, UNITED STATES, April 3, 2025 /⁨EINPresswire.com⁩/ -- Ace Therapeutics is a service provider providing integrated solutions for innovative drug development in the preclinical stage of diabetes mellitus (DM) and its complications. Recently, the company has once again raised the bar with the unveiling of its advanced animal models that have been engineered to drive forward discoveries in diabetic wound healing. These models are set to supplement the way researchers approach this complex and …

    Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
  • Published on November 29, 2024 - 08:08 GMT

    Ace Therapeutics Unveils Custom In Vivo Ocular Modeling Services to Power Up Ophthalmology Research

    To accelerate ophthalmology research and enhance discovery of therapeutic interventions, Ace Therapeutics announced its custom in vivo ocular modeling services. NEW YORK, NY, UNITED STATES, November 29, 2024 /⁨EINPresswire.com⁩/ -- Ace Therapeutics announced the launch of its custom in vivo ocular modeling services, designed to accelerate advancements in ophthalmology research and enhance the discovery of therapeutic interventions. This groundbreaking service provides researchers with tailored animal …

    Distribution channels: Business & Economy, Companies ...
  • Published on September 27, 2024 - 10:45 GMT

    Ace Therapeutics Announces ADME/DMPK Services to Advance Stroke Drug Development

    Ace Therapeutics is excited to announce the expansion of its services with the addition of ADME/DMPK services to support stroke drug development. NEW YORK, NY, UNITED STATES, September 27, 2024 /⁨EINPresswire.com⁩/ -- Ace Therapeutics, one of the leading preclinical CRO companies for stroke, is excited to announce the expansion of its services with the addition of ADME/DMPK services to support stroke drug development. Drug metabolism and pharmacokinetics (DMPK) play a crucial role in the drug …

    Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
  • Published on August 27, 2024 - 09:15 GMT

    Ace Therapeutics Unveils Model Development Services to Power Up Psychiatric Drug R&D

    Ace Therapeutics has announced the launch of its model development services aiming at revolutionizing psychiatric drug research and development. NEW YORK, NY, USA, August 27, 2024 /⁨EINPresswire.com⁩/ -- Ace Therapeutics, a preclinical contract research organization (CRO) actively engaged in mental illness research, has announced the launch of its model development services, which aim to revolutionize psychiatric drug research and development. Psychiatric drug development is a crucial aspect of mental …

    Distribution channels: Business & Economy, Companies ...
  • Published on August 9, 2024 - 08:33 GMT

    Ace Therapeutics Unveils Next-Generation Drug Delivery Technologies for Glaucoma

    Ace Therapeutics is proud to announce the unveiling of its cutting-edge drug delivery system development services for the treatment of glaucoma. NEW YORK, NY, UNITED STATES, August 9, 2024 /⁨EINPresswire.com⁩/ -- Ace Therapeutics is a preclinical contract research provider engaged in metabolic disorders, infectious diseases and parasites, neurological disorders, ophthalmic diseases, gastrointestinal disorders, and immune system diseases. To help pharmaceutical partners and academic institutions overcome …

    Distribution channels: Business & Economy, Companies ...
  • Published on July 30, 2024 - 10:16 GMT

    Rdcthera Releases RDC Development Services to Drive Forward Drug Research and Development

    Rdcthera announced today the release of its revolutionary RDC development services aimed at expediting the bioconjugation drug development process. NEW YORK, NY, USA, July 30, 2024 /⁨EINPresswire.com⁩/ -- Rdcthera, an expert in radionuclide drug conjugate design, conjugation, and analysis, announced today the release of its revolutionary RDC development services aimed at expediting the bioconjugation drug development process and driving forward scientific advancements in the field of healthcare. RDC is …

    Distribution channels: Business & Economy, Companies ...
  • Published on July 24, 2024 - 06:20 GMT

    Ace Therapeutics Accelerates Preclinical GI and Hepatology Research with Disease Model Customization Services

    Ace Therapeutics recently unveiled disease model customization services to accelerate further the preclinical research on gastroenterology (GI) and hepatology. NEW YORK, NY, UNITED STATES, July 24, 2024 /⁨EINPresswire.com⁩/ -- Ace Therapeutics is a preclinical contract research provider engaged in metabolic disorders, infectious diseases and parasites, neurological disorders, ophthalmic diseases, gastrointestinal disorders, and immune system diseases. Following with the announcement of developing small …

    Distribution channels: Business & Economy, Companies ...
  • Published on July 5, 2024 - 08:17 GMT

    Ace Therapeutics Announces Vaccine Development Services Against Superbugs

    With the rise of superbugs posing a significant threat to global public health, Ace Therapeutics announces vaccine development services to address this problem. NEW YORK, NY, UNITED STATES, July 5, 2024 /⁨EINPresswire.com⁩/ -- Ace Therapeutics is a preclinical contract research provider engaged in metabolic disorders, infectious diseases and parasites, neurological disorders, ophthalmic diseases, gastrointestinal disorders, and immune system diseases. With the rise of antibiotic-resistant bacteria posing a …

    Distribution channels: Banking, Finance & Investment Industry, Companies ...
  • Published on June 20, 2024 - 07:04 GMT

    Ace Therapeutics Offers One-Stop Shop for Glaucoma In Vivo Study

    Ace Therapeutics is pleased to announce that it offers clients a comprehensive range of services for preclinical in vivo studies focused on glaucoma research. NEW YORK, NY, UNITED STATES, June 20, 2024 /⁨EINPresswire.com⁩/ -- Ace Therapeutics, a leading provider of preclinical research services, is pleased to announce that it offers clients a comprehensive range of services for preclinical in vivo studies focused on glaucoma research. With a team of experienced researchers and cutting-edge ophthalmic …

    Distribution channels: Business & Economy, Companies ...
Contact
Daisy Mostert
Ace Therapeutics
+1 516 441 0167
Share This Newsroom
Company/Organization
Ace Therapeutics
500-A Wheeler Rd
Hauppauge, New York, 11788
United States
+1 516 441 0167
Visit Website
About

Ace Therapeutics is a preclinical contract research provider dedicated to offering comprehensive one-stop services. Our expertise spans various preclinical services, including efficacy testing, pharmacokinetics, toxicology, and biomarker development, to support clients in their research and development efforts.

Ace Therapeutics